Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.

Session and Conference Chair

Gregory W. Mattingly, MD

Associate Clinical Professor
Washington University School of Medicine
President, Midwest Research Group
President-Elect
APSARD - American Professional Society for ADHD and Related Disorders
St. Louis, Missouri

Disclosures

Gregory W. Mattingly, MD, has the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie, Inc; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Axsome Therapeutics, Inc.; Corium Inc.; Eisai, Inc; Ironshore Pharmaceuticals, Inc.; Intra-Cellular Therapies, Inc; Janssen; Lundbeck, Inc.; Neos Therapeutics, Inc.; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Redax; Rhodes Pharmaceuticals L.P.; Roche; Sage Therapeutics; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, inc.; Takeda; Teva; Tris Pharma, Inc.
Received grants for clinical research from: AbbVie, Inc.; Alkermes, Inc.; Corium Inc.; Eisai, Inc.; Intra-Cellular Therapies, Inc.; Ironshore Pharmaceuticals, Inc.; Janssen; Lundbeck, Inc.; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Tris Pharma, Inc.
Contracted researcher for: AbbVie, Inc.; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Akili Interactive Labs, inc.; Axsome Therapeutics, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Emalex Biosciences; Idorsia Pharmaceuticals, Inc.; Janssen; Karuna Therapeutics; Lumos Labs; Medgenics; NLS-1 Pharma AG; Redax; Relmada Therapeutics, Inc.; Roche; Sage Therapeutics; Sirtsei Pharmaceuticals, Inc.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Teva Neuroscience, Inc.

Faculty

Rachel Brown, MBBS

Professor and Chair
Psychiatry and Behavioral Sciences
The University of Kansas School of Medicine
Wichita, Kansas

Disclosures

Rachel Brown, MBBS, has no relevant financial relationships.

Jon E. Grant, MD, JD, MPH

Professor of Psychiatry
University of Chicago
Chicago, Illinois

Disclosures

Jon E. Grant, MD, JD, MPH, has the following relevant financial relationships:
Received grants for clinical research from: Biohaven Pharmaceuticals; Otsuka Pharmaceutical Co., Ltd.

Amanda J. Simonton, PhD, APRN, PMHNP-BC

Clinical Assistant Professor
School of Nursing
The University of Texas at Austin
Psychiatric Nurse Practitioner
Texas Child Study Center
Dell Children's Medical Center
Psychiatric Nurse Practitioner
CARMA Health
Austin, Texas

Disclosures

Amanda J. Simonton, PhD, APRN, PMHNP-BC, has the following relevant financial relationships:
Served as an advisor or consultant for: Alkermes Inc. (former); Corium Inc. (former)

Kristin Sohl, MD, FAAP

Professor
Department of Child Health
Executive Director
Extension for Community Healthcare Outcomes (ECHO) Autism
University of Missouri
Columbia, Missouri

Disclosures

Kristin Sohl, MD, FAAP, has the following relevant financial relationships:
Served as an advisor or consultant for: Cognoa, Inc. (former); Quadrant Biosciences
Received grants for clinical research from: Cognoa, Inc.

Editor

Clinton W. Wright, PharmD, BCPP

Medical Education Director, Medscape, LLC

Disclosures

Clinton W. Wright, PharmD, BCPP, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME / ABIM MOC / CE

Current Challenges in Child and Adolescent Psychiatry

Authors: Rachel Brown, MBBS; Jon E. Grant, MD, JD, MPH; Gregory W. Mattingly, MD; Amanda J. Simonton, PhD, APRN, PMHNP-BC; Kristin Sohl, MD, FAAP
CME / ABIM MOC / CE Released: 12/21/2022
Valid for credit through: 12/21/2023

Start Activity

Credits Available

Physicians - maximum of 2.50 AMA PRA Category 1 Credit(s)™

ABIM Diplomates - maximum of 2.50 ABIM MOC points

Nurses - 2.50 ANCC Contact Hour(s) (1 contact hours are in the area of pharmacology)

IPCE: 2.50 Interprofessional Continuing Education (IPCE) credit

You Are Eligible For
- Letter of Completion
- ABIM MOC points

Target Audience and Goal Statement

This activity is intended for psychiatrists, neurologists, nurse practitioners (NPs), primary care physicians (PCPs), pediatricians, physician assistants (PAs), nurses, pharmacists, and other healthcare practitioners (HCPs) who provide care to pediatric patients with neuropsychiatric disorders.

The goal of this activity is for learners to be better able to screen, diagnose, and manage pediatric patients with neuropsychiatric and psychiatric disorders.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Impact of the COVID-19 pandemic on the prevalence of and risks for behavioral health disorders in pediatric patients
- Recent clinical data on emerging and novel interventions for ADHD
- Recent clinical data on emerging and novel tools for autism spectrum disorder (ASD) screening and diagnosis
- Regarding the up-to-date evidence on clinical interventions for pediatric patients with ASD
Have greater competence related to
- Implementing best practices in pharmacologic and non-pharmacologic management of obsessive-compulsive disorder (OCD) in adolescent patients
Demonstrate greater confidence in their ability to
- Incorporate interprofessional strategies into adolescent psychiatric care

Disclosures

Disclosures for additional planners can be found here.

Session and Conference Chair

Gregory W. Mattingly, MD

Associate Clinical Professor
Washington University School of Medicine
President, Midwest Research Group
President-Elect
APSARD - American Professional Society for ADHD and Related Disorders
St. Louis, Missouri

Disclosures

Gregory W. Mattingly, MD, has the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie, Inc; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Axsome Therapeutics, Inc.; Corium Inc.; Eisai, Inc; Ironshore Pharmaceuticals, Inc.; Intra-Cellular Therapies, Inc; Janssen; Lundbeck, Inc.; Neos Therapeutics, Inc.; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Redax; Rhodes Pharmaceuticals L.P.; Roche; Sage Therapeutics; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, inc.; Takeda; Teva; Tris Pharma, Inc.
Received grants for clinical research from: AbbVie, Inc.; Alkermes, Inc.; Corium Inc.; Eisai, Inc.; Intra-Cellular Therapies, Inc.; Ironshore Pharmaceuticals, Inc.; Janssen; Lundbeck, Inc.; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Tris Pharma, Inc.
Contracted researcher for: AbbVie, Inc.; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Akili Interactive Labs, inc.; Axsome Therapeutics, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Emalex Biosciences; Idorsia Pharmaceuticals, Inc.; Janssen; Karuna Therapeutics; Lumos Labs; Medgenics; NLS-1 Pharma AG; Redax; Relmada Therapeutics, Inc.; Roche; Sage Therapeutics; Sirtsei Pharmaceuticals, Inc.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Teva Neuroscience, Inc.

Faculty

Rachel Brown, MBBS

Professor and Chair
Psychiatry and Behavioral Sciences
The University of Kansas School of Medicine
Wichita, Kansas

Disclosures

Rachel Brown, MBBS, has no relevant financial relationships.

Jon E. Grant, MD, JD, MPH

Professor of Psychiatry
University of Chicago
Chicago, Illinois

Disclosures

Jon E. Grant, MD, JD, MPH, has the following relevant financial relationships:
Received grants for clinical research from: Biohaven Pharmaceuticals; Otsuka Pharmaceutical Co., Ltd.

Amanda J. Simonton, PhD, APRN, PMHNP-BC

Clinical Assistant Professor
School of Nursing
The University of Texas at Austin
Psychiatric Nurse Practitioner
Texas Child Study Center
Dell Children's Medical Center
Psychiatric Nurse Practitioner
CARMA Health
Austin, Texas

Disclosures

Amanda J. Simonton, PhD, APRN, PMHNP-BC, has the following relevant financial relationships:
Served as an advisor or consultant for: Alkermes Inc. (former); Corium Inc. (former)

Kristin Sohl, MD, FAAP

Professor
Department of Child Health
Executive Director
Extension for Community Healthcare Outcomes (ECHO) Autism
University of Missouri
Columbia, Missouri

Disclosures

Kristin Sohl, MD, FAAP, has the following relevant financial relationships:
Served as an advisor or consultant for: Cognoa, Inc. (former); Quadrant Biosciences
Received grants for clinical research from: Cognoa, Inc.

Editor

Clinton W. Wright, PharmD, BCPP

Medical Education Director, Medscape, LLC

Disclosures

Clinton W. Wright, PharmD, BCPP, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 2.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For Nurses

Awarded 2.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours are in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Psychiatry & Mental Health

CME / ABIM MOC / CE

Current Challenges in Child and Adolescent Psychiatry

Authors: Rachel Brown, MBBS; Jon E. Grant, MD, JD, MPH; Gregory W. Mattingly, MD; Amanda J. Simonton, PhD, APRN, PMHNP-BC; Kristin Sohl, MD, FAAPFaculty and Disclosures

CME / ABIM MOC / CE Released: 12/21/2022

Valid for credit through: 12/21/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Unpacking the Impact of COVID-19 on Pediatric Mental Health

Quantifying COVID-19's impact on youth mental health: Where do we stand 2 years later?
Amanda J. Simonton, PhD, APRN, PMHNP-BC

Innovations in ADHD: Updates in Pharmacologic and Nonpharmacologic Therapeutics

How does life change developmentally for individuals with ADHD? Learn this and more from world-renowned experts
Gregory W. Mattingly, MD

Best Practices in OCD Management in Adolescents

Are you up to date on OCD in adolescents? It's more than just handwashing
Jon E. Grant, MD, JD, MPH

Opening the Door to Earlier Recognition: Advancements in the Screening and Diagnosis of Autism Spectrum Disorder

Developmental surveillance: Can you identify abnormalities in social communication?
Kristin Sohl, MD, FAAP

The Management of Autism Spectrum Disorder

Start low and go slow. Did you know that there are higher rates of sides effects and that responses may be unpredictable?
Rachel Brown, MBBS

Educational Impact Challenge

The goal of this activity is for learners to be better able to screen, diagnose, and manage pediatric patients with neuropsychiatric and psychiatric disorders.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

Page 1 of 8

CME / ABIM MOC / CE Information Download Slides

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Session and Conference Chair

Gregory W. Mattingly, MD

Faculty

Rachel Brown, MBBS

Jon E. Grant, MD, JD, MPH

Amanda J. Simonton, PhD, APRN, PMHNP-BC

Kristin Sohl, MD, FAAP

Editor

Clinton W. Wright, PharmD, BCPP

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

CME / ABIM MOC / CE

Current Challenges in Child and Adolescent Psychiatry

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Session and Conference Chair

Gregory W. Mattingly, MD

Faculty

Rachel Brown, MBBS

Jon E. Grant, MD, JD, MPH

Amanda J. Simonton, PhD, APRN, PMHNP-BC

Kristin Sohl, MD, FAAP

Editor

Clinton W. Wright, PharmD, BCPP

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

Current Challenges in Child and Adolescent Psychiatry

Contents of This CME Activity

Unpacking the Impact of COVID-19 on Pediatric Mental Health

Innovations in ADHD: Updates in Pharmacologic and Nonpharmacologic Therapeutics

Best Practices in OCD Management in Adolescents

Opening the Door to Earlier Recognition: Advancements in the Screening and Diagnosis of Autism Spectrum Disorder

The Management of Autism Spectrum Disorder

Educational Impact Challenge